Model for: global longitudinal strain (GLS) [%] | |||||
---|---|---|---|---|---|
Intercept | RA # | Arterial hypertension # | Anti-cyclic citrullinated peptide (anti-CCP) [EU/ml] | Neutrophil gelatinase-associated lipocalin (NGAL) [ng/ml] | |
A. Risk factors for global longitudinal strain (GLS) reduction | |||||
Regression coefficient | −40.663 | 3.519 | 2.939 | 0.005 | 0.333 |
SEM of Rc | 15.441 | 1.241 | 1.302 | 0.002 | 0.121 |
p | 0.005 | 0.006 | 0.042 | 0.027 | 0.009 |
Model for: global circumferential strain (GCS) [%] | |||||||
---|---|---|---|---|---|---|---|
Intercept | RA# | Type 2 diabetes# | Smoking# | Anti-cyclic citrullinated peptide (anti-CCP) [EU/ml] | Steroids # | Methotrexate# | |
B. Risk factors for global circumferential strain (GCS) reduction | |||||||
Regression coefficient | −37.042 | 2.332 | 8.309 | 4.651 | 0.004 | −3.175 | 4.057 |
SEM of Rc | 5.279 | 0.994 | 2.336 | 1.916 | 0.002 | 1.546 | 1.592 |
p | 0.001 | 0.023 | 0.001 | 0.019 | 0.035 | 0.045 | 0.014 |